Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Hematological Oncology|January 14, 2026
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient JourneyLisa Argnani, Cinzia Pellegrini, Ombretta Annibali, et al.
Bone Marrow Transplantation|July 2, 2026
Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patientsAttilio Olivieri, Giorgia Mancini, Jacopo Olivieri, et al.
Blood Advances|June 5, 2023
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphomaAnnalisa Arcari, Lugi Rigacci, Alessandra Tucci, et al.
Bone Marrow Transplantation|April 13, 2022
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01Francesca Bonifazi, Chiara Pavoni, Jacopo Peccatori, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2014
Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)Corrado Girmenia, Anna Maria Raiola, Alfonso Piciocchi, et al.
Oncotarget|April 22, 2017
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratoriesMargherita Perricone, Francesca Palandri, Emanuela Ottaviani, et al.
Oncotarget|December 7, 2017
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphomaCinzia Pellegrini, Alessandro Broccoli, Alessandro Pulsoni, et al.
American Journal of Hematology|June 2, 2025
Clinical Impact of Graft Cryopreservation on Allogeneic Stem Cell Transplantation: An Italian, Registry-Based Study on Behalf of the "Gruppo Italiano Per Il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare" (GITMO)Irene Defrancesco, Virginia Valeria Ferretti, Patrizia Chiusolo, et al.
Cancer|March 20, 2025
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI)Massimo Breccia, Francesca Palandri, Maurizio Martelli, et al.
Hematological Oncology|March 25, 2026
Clinical Outcomes of Ruxolitinib Treatment in Patients With IPSS Intermediate-1-Risk Myelofibrosis: Interim Analysis From an Italian, Prospective Study (ROMEI)Paola Guglielmelli, Massimo Breccia, Francesco Mendicino, et al.
Pageof 8